Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,493 SEC EDGAR filings since 02 Feb 1996

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page
25
Current page
15
8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date
10 May 2023
Reporting date
10 May 2023
Next action
Verify source filing
ARS File 001-16174

ARS

Filing date
19 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-16174

DEFA14A

Filing date
19 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2023
Reporting date
06 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-260519

424B5

Filing date
03 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .